8-K - Sensei Biotherapeutics, Inc. - 5.02
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-158951
Filing Date: 2026-04-16
Accepted: 2026-04-16 16:02:13
Documents: 12
Period of Report: 2026-04-10
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Sensei Biotherapeutics, Inc. (Filer) CIK : 0001829802 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 26867466 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | d85136d8k.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA | snse-20260410.xsd | EX-101.SCH
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | snse-20260410_def.xml | EX-101.DEF
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | snse-20260410_lab.xml | EX-101.LAB